RSS Marijuana Investing News
  • Marijuana News Is Moving December 19, 2018
    News content on is being reborn as Weedmaps News at While our URL has changed, you can still find breaking news, political coverage, science explainers, and deep dives into the culture of cannabis. The archives remain available, with the exception of recent selections that have transferred to Weedmaps News. While won’t […]
    Nicolas Juarez
  • Rights Groups, Unions Call for Ending Marijuana Prohibition December 14, 2018
    A coalition of major civil rights organizations, labor unions and other groups is calling on Congress to completely remove marijuana from the Controlled Substances Act and divert revenue to communities that have been harmed by the enforcement of cannabis prohibition.   “Pass legislation de-scheduling marijuana with racial equity and justice reform components,” reads one recommendation […]
    Marijuana Moment
  • How Trump Government Shutdown Threat Could Affect Marijuana December 13, 2018
    President Donald Trump is threatening to shut down the government if Democrats refuse billions of dollars in funding for a border wall — but the consequences of that action would extend far beyond border security. WASHINGTON (AP) — Trump threatens gov't shutdown in heated meeting with Dem leaders over border wall, squabbling over election results. […]
    Marijuana Moment
  • Elon Musk Confesses: ‘I Have No Idea How To Smoke Pot’ December 12, 2018
    Elon Musk got himself into a bit of trouble after smoking marijuana during an appearance on Joe Rogan’s podcast in September 2018. The move reportedly led to NASA launching an investigation into his company SpaceX’s “workplace safety” and “adherence to a drug-free environment.” But now, in a new interview 60 Minutes, the Tesla founder indicated […]
    Marijuana Moment
  • Cannabis May Qualify for Study Grants as ‘Natural Product’ December 11, 2018
    Federally funded research into marijuana seems to be escalating, with one government agency recently posting a roundup of current “cannabinoid-related funding opportunities” for studies investigating the plant’s therapeutic potential. The National Center for Complementary and Integrative Health (NCCIH) on Dec. 8, 2018, shared a list of four research grant opportunities for studies on “natural products” […]
    Marijuana Moment
  • Surgeon General: Schedule I Hinders Researching Marijuana December 7, 2018
    U.S. Surgeon General Jerome Adams said the federal government should rethink how it classifies drugs like marijuana Dec. 6, 2018, voicing concern that the plant’s current status as a strictly controlled Schedule I substance inhibits research. Adams, who’s previously expressed interest in expanding research into the use of cannabinoids for therapeutic purposes, made the comment […]
    Marijuana Moment
  • Colorado County Considers Canceling Cannabis Convictions December 6, 2018
    BOULDER, Colo. (AP) — Prosecutors in a Colorado county are preparing to dismiss and seal thousands of marijuana possession convictions after state voters legalized the use and sale of cannabis in 2012. The Boulder Daily Camera reported that the Boulder County District Attorney’s Office as part of a “Moving on from Marijuana” program has identified […]
    Associated Press
  • GOP House Leader Calling for Legal Marijuana in Rhode Island December 5, 2018
    The Republican leader in Rhode Island’s House of Representatives thinks the state should fully legalize marijuana. But while that news would typically bode well for reform efforts in state legislatures, the problem is that the Democratic speaker isn’t quite on board — and the House is dominantly controlled by Democrats. In an interview with Rhode […]
    Marijuana Moment
  • ‘Compromise’ Medical Marijuana Bill is Made Into Law in Utah December 4, 2018
    Utah lawmakers approved a controversial medical marijuana bill in a special session Dec. 3, 2018. There’s your final vote on the medical marijuana “compromise.” #utpol — Robert Gehrke (@RobertGehrke) December 3, 2018 During the Nov. 6, 2018, election, Utah voters passed a separate medical cannabis initiative, Proposition 2, that would allow patients with certain […]
    Marijuana Moment
  • Study: Vaporizing Flower Produces A More Intense High Than Traditional Smoking Methods December 4, 2018
    Vaping marijuana flower gets you higher than smoking it, according to a new study published in an American Medical Association journal. To test the difference, researchers started by recruiting 17 people who’d consumed cannabis in the past year but had abstained for at least one month. Each individual participated in six sessions that lasted 8 1/2 […]
    Marijuana Moment
mentor36 June 11, 2019

The Economist wrote in 2016 that the argument for the legalization of marijuana had been won.

“Now for the difficult bit,” the influential global business magazine stated at the time, “the start of complex arguments about how to regulate cannabis.”

Three years later, those debates are playing out in more parliaments, civil services and societies than ever – although mostly for medical.

Those issues were front and center as the magazine held its inaugural Cannabis Summit in Toronto last week, bringing together a broad range of participants, including industry players, regulators, statisticians and health-care professionals.

Hard questions involving policy and investment opportunities were asked at the daylong event.

“There’s a lot of policy implications, business opportunities and social effects to be thought through,” said Daniel Franklin, The Economist’s executive and diplomatic editor. “So, I think it’s an ideal intersection of issues where we can help to bring people together to puzzle this out, and also to bring a certain cross-fertilization of ideas from different parts of the world that had been grappling with similar issues.”

The Economist, based in London, is a long-standing backer of cannabis legalization.

“We wouldn’t be doing it if we didn’t think it was both an important issue and an important business potentially,” Franklin said about the conference. “And all the signs are that there is serious investment going into the industry.”

Marijuana Business Daily sat down with Franklin to talk about cannabis legalization, policy and global trends.

How do you see this playing out in the months and years ahead? 

We have long been advocates of legalization, well before it started to happen in a serious way. But we’re also very mindful that it’s complicated territory, and it needs to be done thoughtfully. There are lots of tricky policy issues to be grappled with. And it’s also potentially big business.

More broadly, in The Economist, we’ve been critical of prohibition. So, legalizing and regulating has been a long-standing editorial policy line.

But at the same time, recognizing that it’s not something you do in a cavalier way. It’s something that needs to be done in as thoughtful an approach as possible, in a way that tackles consequences which may not be instantly obvious. And drawing on all the experience that you can from places that are starting to experiment with it.

And every country is going to proceed at its own pace, in its own way, correct? 

One of the things that we’re hearing about today at this conference is that this is complicated stuff. This is difficult stuff.

It’s probably a good thing that it doesn’t happen all at the same time, all in the same way, (instead) with a degree of experimentation and drawing on lessons from places that are further ahead than others.

How does the cannabis industry get more mainstream?

One of the things that struck me today is that there’s clearly a big sense of opportunity.

Big numbers are put around, and that’s clearly true. A lot of people, a lot of major companies are moving in, and there’s also a certain amount of celebrity investing going on. There’s also a lot of innovation happening in the industry.

But one of the things that struck me was that there is also still quite a high degree of risk in the industry. One shouldn’t play down the barriers and the potential problems that could arise from a regulatory backlash.

So, there’s investment risk, and that weighs on the industry at the same time.

Is there a little too much hype involved?

There’s typically in a newly legalized industry a hype cycle. You get people very excited, and then there’s bound to be some disappointment, compared with the initial hype.

But quite often it turns out that it’s actually underplayed, and it might even bigger than people imagined. I don’t know if that’s going to repeat here, but I think it’s almost inevitable that some of the hype will prove to be excessive, but I think there’s something very real as well.

This interview has been edited for length and clarity.

Matt Lamers can be reached at [email protected]

© 2018 Highline Media Group